Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
64,326,281
-
Total 13F shares
-
14,513,290
-
Share change
-
+14,513,290
-
Total reported value
-
$186,104,000
-
Price per share
-
$13.25
-
Number of holders
-
21
-
Value change
-
+$186,103,943
-
Number of buys
-
21
Institutional Holders of Vera Therapeutics, Inc. - COMMON STOCK (VERA) as of Q2 2021
As of 30 Jun 2021 Vera Therapeutics, Inc. - COMMON STOCK (VERA) had 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 14,513,290 shares of stock of the company.
Largest 10 holders included FMR LLC, Abingworth LLP, Sofinnova Investments, Inc., CITADEL ADVISORS LLC, KPCB XVI Associates, LLC, Octagon Capital Advisors LP, Alphabet Inc., MILLENNIUM MANAGEMENT LLC, Parkman Healthcare Partners LLC, and VANGUARD GROUP INC.
This table shows 21 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.